Review



antibody against opn  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Proteintech antibody against opn
    Antibody Against Opn, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 523 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody against opn/product/Proteintech
    Average 96 stars, based on 523 article reviews
    antibody against opn - by Bioz Stars, 2026-03
    96/100 stars

    Images



    Similar Products

    99
    Thermo Fisher gene exp spp1 hs00959010 m1
    Gene Exp Spp1 Hs00959010 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gene exp spp1 hs00959010 m1/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    gene exp spp1 hs00959010 m1 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    94
    MedChemExpress recombinant opn protein
    Recombinant Opn Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant opn protein/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    recombinant opn protein - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    96
    Proteintech antibody against opn
    Antibody Against Opn, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody against opn/product/Proteintech
    Average 96 stars, based on 1 article reviews
    antibody against opn - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    Proteintech opn
    Effects on osteogenesis and angiogenesis of the NGF-G/P@Yoda1-stimulated neural cells. (A) Schematic diagram illustrating co-culture models of different composite hydrogels with RSC96 and PC-12, along with the collection of co-culture supernatant as the condition medium for BMSCs and HUVECs cultivation. (B–D) ALP staining at day 7 to assess early osteogenic capacity and Alizarin Red S (ARS) staining at day 21 to assess late-stage calcified nodule formation of BMSCs and semi-quantitative analyses. (E–H) Immunofluorescence staining at day 7 to evaluate expression of osteogenic marker proteins COL1A and <t>OPN</t> and semi-quantitative analysis of mean flourscence indensity (MFI). (I, J) Western blot to evaluate the expression of downstream proteins and osteogenic markers mediated <t>by</t> <t>CGRP</t> and semi-quantitative analysis. (K, L) Wound healing assay and healing ratio quantitative analysis to asses migration capacity of HUVECs. (M, N) Transwell assay and relative quantitative analysis of HUVECs' migration. (O–Q) Tube formation assay and quantification of number of nodes and number of tubes to assess angiogenic capacity of HUVECs. The quantitative data (n ≥ 3) in the figures represent as the averages ± SD, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
    Opn, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/opn/product/Proteintech
    Average 96 stars, based on 1 article reviews
    opn - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    94
    MedChemExpress opn group
    Effects on osteogenesis and angiogenesis of the NGF-G/P@Yoda1-stimulated neural cells. (A) Schematic diagram illustrating co-culture models of different composite hydrogels with RSC96 and PC-12, along with the collection of co-culture supernatant as the condition medium for BMSCs and HUVECs cultivation. (B–D) ALP staining at day 7 to assess early osteogenic capacity and Alizarin Red S (ARS) staining at day 21 to assess late-stage calcified nodule formation of BMSCs and semi-quantitative analyses. (E–H) Immunofluorescence staining at day 7 to evaluate expression of osteogenic marker proteins COL1A and <t>OPN</t> and semi-quantitative analysis of mean flourscence indensity (MFI). (I, J) Western blot to evaluate the expression of downstream proteins and osteogenic markers mediated <t>by</t> <t>CGRP</t> and semi-quantitative analysis. (K, L) Wound healing assay and healing ratio quantitative analysis to asses migration capacity of HUVECs. (M, N) Transwell assay and relative quantitative analysis of HUVECs' migration. (O–Q) Tube formation assay and quantification of number of nodes and number of tubes to assess angiogenic capacity of HUVECs. The quantitative data (n ≥ 3) in the figures represent as the averages ± SD, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
    Opn Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/opn group/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    opn group - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress mouse ropn protein
    Effects on osteogenesis and angiogenesis of the NGF-G/P@Yoda1-stimulated neural cells. (A) Schematic diagram illustrating co-culture models of different composite hydrogels with RSC96 and PC-12, along with the collection of co-culture supernatant as the condition medium for BMSCs and HUVECs cultivation. (B–D) ALP staining at day 7 to assess early osteogenic capacity and Alizarin Red S (ARS) staining at day 21 to assess late-stage calcified nodule formation of BMSCs and semi-quantitative analyses. (E–H) Immunofluorescence staining at day 7 to evaluate expression of osteogenic marker proteins COL1A and <t>OPN</t> and semi-quantitative analysis of mean flourscence indensity (MFI). (I, J) Western blot to evaluate the expression of downstream proteins and osteogenic markers mediated <t>by</t> <t>CGRP</t> and semi-quantitative analysis. (K, L) Wound healing assay and healing ratio quantitative analysis to asses migration capacity of HUVECs. (M, N) Transwell assay and relative quantitative analysis of HUVECs' migration. (O–Q) Tube formation assay and quantification of number of nodes and number of tubes to assess angiogenic capacity of HUVECs. The quantitative data (n ≥ 3) in the figures represent as the averages ± SD, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
    Mouse Ropn Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse ropn protein/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    mouse ropn protein - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    99
    Thermo Fisher gene exp spp1 mm00436767 m1
    Effects on osteogenesis and angiogenesis of the NGF-G/P@Yoda1-stimulated neural cells. (A) Schematic diagram illustrating co-culture models of different composite hydrogels with RSC96 and PC-12, along with the collection of co-culture supernatant as the condition medium for BMSCs and HUVECs cultivation. (B–D) ALP staining at day 7 to assess early osteogenic capacity and Alizarin Red S (ARS) staining at day 21 to assess late-stage calcified nodule formation of BMSCs and semi-quantitative analyses. (E–H) Immunofluorescence staining at day 7 to evaluate expression of osteogenic marker proteins COL1A and <t>OPN</t> and semi-quantitative analysis of mean flourscence indensity (MFI). (I, J) Western blot to evaluate the expression of downstream proteins and osteogenic markers mediated <t>by</t> <t>CGRP</t> and semi-quantitative analysis. (K, L) Wound healing assay and healing ratio quantitative analysis to asses migration capacity of HUVECs. (M, N) Transwell assay and relative quantitative analysis of HUVECs' migration. (O–Q) Tube formation assay and quantification of number of nodes and number of tubes to assess angiogenic capacity of HUVECs. The quantitative data (n ≥ 3) in the figures represent as the averages ± SD, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
    Gene Exp Spp1 Mm00436767 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gene exp spp1 mm00436767 m1/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    gene exp spp1 mm00436767 m1 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    Image Search Results


    Effects on osteogenesis and angiogenesis of the NGF-G/P@Yoda1-stimulated neural cells. (A) Schematic diagram illustrating co-culture models of different composite hydrogels with RSC96 and PC-12, along with the collection of co-culture supernatant as the condition medium for BMSCs and HUVECs cultivation. (B–D) ALP staining at day 7 to assess early osteogenic capacity and Alizarin Red S (ARS) staining at day 21 to assess late-stage calcified nodule formation of BMSCs and semi-quantitative analyses. (E–H) Immunofluorescence staining at day 7 to evaluate expression of osteogenic marker proteins COL1A and OPN and semi-quantitative analysis of mean flourscence indensity (MFI). (I, J) Western blot to evaluate the expression of downstream proteins and osteogenic markers mediated by CGRP and semi-quantitative analysis. (K, L) Wound healing assay and healing ratio quantitative analysis to asses migration capacity of HUVECs. (M, N) Transwell assay and relative quantitative analysis of HUVECs' migration. (O–Q) Tube formation assay and quantification of number of nodes and number of tubes to assess angiogenic capacity of HUVECs. The quantitative data (n ≥ 3) in the figures represent as the averages ± SD, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.

    Journal: Bioactive Materials

    Article Title: Composite hydrogel-microsphere delivery system promotes early nerve-mediated bone regeneration and late-stage mechanotransduction-driven bone remodeling via sequential release of NGF and Yoda1

    doi: 10.1016/j.bioactmat.2025.10.040

    Figure Lengend Snippet: Effects on osteogenesis and angiogenesis of the NGF-G/P@Yoda1-stimulated neural cells. (A) Schematic diagram illustrating co-culture models of different composite hydrogels with RSC96 and PC-12, along with the collection of co-culture supernatant as the condition medium for BMSCs and HUVECs cultivation. (B–D) ALP staining at day 7 to assess early osteogenic capacity and Alizarin Red S (ARS) staining at day 21 to assess late-stage calcified nodule formation of BMSCs and semi-quantitative analyses. (E–H) Immunofluorescence staining at day 7 to evaluate expression of osteogenic marker proteins COL1A and OPN and semi-quantitative analysis of mean flourscence indensity (MFI). (I, J) Western blot to evaluate the expression of downstream proteins and osteogenic markers mediated by CGRP and semi-quantitative analysis. (K, L) Wound healing assay and healing ratio quantitative analysis to asses migration capacity of HUVECs. (M, N) Transwell assay and relative quantitative analysis of HUVECs' migration. (O–Q) Tube formation assay and quantification of number of nodes and number of tubes to assess angiogenic capacity of HUVECs. The quantitative data (n ≥ 3) in the figures represent as the averages ± SD, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.

    Article Snippet: Primary antibodies included IL-1β (GB11113, Servicebio, Wuhan, China), CD31 (ab222783, Abcam, UK), EMCN ( GB112648 , Servicebio, Wuhan, China), OPN (22952-1-AP, Proteintech, Wuhan, China), OCN (A6205, ABclonal, Wuhan, China), TUBB3, CGRP, p-YAP1, β-catenin, COL1A, and RUNX2.

    Techniques: Co-Culture Assay, Staining, Immunofluorescence, Expressing, Marker, Western Blot, Wound Healing Assay, Migration, Transwell Assay, Tube Formation Assay

    Effect of NGF-G/P@Yoda1 on promoting bone regeneration and bone remodeling in femur def ect model. (A–D) Representative immunohistochemical staining images at week 8 for RUNX2 and OPN and semi-quantitative analysis of positive areas to evaluate the osteogenic capacity of composite hydrogels. (E, F) Representative immunofluorescence (IF) staining images at week 8 of OCN and semi-quantitative analysis. (G–J) Representative IF staining images at week 8 of YAP1and β-catenin and semi-quantitative analyses. (K, L) Representative TRAP staining images at week 8 and semi-quantitative analysis of positive areas to assess bone resorption and remodeling. The quantitative data (n ≥ 3) in the figures represent as the averages ± SD, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.

    Journal: Bioactive Materials

    Article Title: Composite hydrogel-microsphere delivery system promotes early nerve-mediated bone regeneration and late-stage mechanotransduction-driven bone remodeling via sequential release of NGF and Yoda1

    doi: 10.1016/j.bioactmat.2025.10.040

    Figure Lengend Snippet: Effect of NGF-G/P@Yoda1 on promoting bone regeneration and bone remodeling in femur def ect model. (A–D) Representative immunohistochemical staining images at week 8 for RUNX2 and OPN and semi-quantitative analysis of positive areas to evaluate the osteogenic capacity of composite hydrogels. (E, F) Representative immunofluorescence (IF) staining images at week 8 of OCN and semi-quantitative analysis. (G–J) Representative IF staining images at week 8 of YAP1and β-catenin and semi-quantitative analyses. (K, L) Representative TRAP staining images at week 8 and semi-quantitative analysis of positive areas to assess bone resorption and remodeling. The quantitative data (n ≥ 3) in the figures represent as the averages ± SD, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.

    Article Snippet: Primary antibodies included IL-1β (GB11113, Servicebio, Wuhan, China), CD31 (ab222783, Abcam, UK), EMCN ( GB112648 , Servicebio, Wuhan, China), OPN (22952-1-AP, Proteintech, Wuhan, China), OCN (A6205, ABclonal, Wuhan, China), TUBB3, CGRP, p-YAP1, β-catenin, COL1A, and RUNX2.

    Techniques: Immunohistochemical staining, Staining, Immunofluorescence